Drug Shortage Report for PMS-CYTARABINE

Last updated on 2024-10-30 History
Report ID 237388
Drug Identification Number 02406772
Brand name PMS-CYTARABINE
Common or Proper name CYTARABINE
Company Name PHARMASCIENCE INC
Market Status MARKETED
Active Ingredient(s) CYTARABINE
Strength(s) 100MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRATHECAL SUBCUTANEOUS INTRAVENOUS INTRATHECAL
Packaging size 10 & 20 ML
ATC code L01BC
ATC description ANTIMETABOLITES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-09-11
Estimated end date 2025-04-01
Actual end date
Shortage status Actual shortage
Updated date 2024-10-30
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2024-10-30 French Compare
v3 2024-10-30 English Compare
v2 2024-09-12 French Compare
v1 2024-09-12 English Compare

Showing 1 to 4 of 4